Entry Detail



General Information

Database ID:exR0089683
RNA Name:hsa-miR-302b-3p
RNA Type:miRNA
Chromosome:chr4
Starnd:-
Coordinate:
Start Site(bp):112648489End Site(bp):112648511
External Links:hsa-miR-302b-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
RPP14
chr3
58306247
58324695
+
SWSAP1
chr19
11374666
11376951
+
GPBP1
chr5
57173948
57264679
+
C18orf21
chr18
35972625
35979286
+
PXYLP1
chr3
141228726
141367753
+
ALG5
chr13
36949738
37000261
-
SERINC1
chr6
122443351
122471807
-
RGMA
chr15
93035273
93089204
-
CLCN6
chr1
11806096
11848079
+
KCTD10
chr12
109448655
109477359
-
PLS3
chrX
115561174
115650861
+
RPLP1
chr15
69452814
69456205
+
DNAJB6
chr7
157335381
157417439
+
SYAP1
chrX
16719612
16765340
+
RNF149
chr2
101271219
101308701
-
SLC35G1
chr10
93893973
93956062
+
MSL1
chr17
40121971
40136917
+
SND1
chr7
127652194
128092609
+
WASF3
chr13
26557683
26688948
+
CTR9
chr11
10751246
10801625
+
HMGCS1
chr5
43287470
43313512
-
CDK6
chr7
92604921
92836594
-
WDR37
chr10
1049538
1132384
+
ATP6V1B2
chr8
20197381
20226819
+
CTSC
chr11
88293592
88337761
-
HSPA9
chr5
138553756
138575416
-
ZNF281
chr1
200404940
200410056
-
CELF2
chr10
10798397
11336675
+
TNRC6A
chr16
24610209
24827632
+
ATP13A2
chr1
16985958
17011928
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC011503.2
chr19
23927788
23929287
+
AC021078.1
chr5
149494314
149504670
-
AC125257.1
chr17
41848518
41851447
-
AL049840.4
chr14
103694516
103695050
-
ARHGAP27P1-BPTFP1-KPNA2P3
chr17
64749663
64781707
-
FGD5-AS1
chr3
14920347
14948424
-
MIR17HG
chr13
91347820
91354579
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
SNHG16
chr17
76557764
76565348
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.